TheraLeaf announces product availability in New Zealand

Barcelona, Spain – May 20th, 2020 TheraLeaf is pleased to announce the launch of our products in New Zealand with 4 varieties of EU GMP pharma grade cannabidiol tinctures. Produced in the EU according to rigorous pharma guidelines, TheraLeaf oils come in 750 mg, 1500 mg, 3000 mg and 4500 mg concentrations. Each 30 ml bottle of organic cannabidiol is …

TheraLeaf signs letter of intent with Medipharm for pharmaceutical grade THC oils

Barcelona, Spain – May 7th, 2020 TheraLeaf has signed a Letter of Intent (LOI) with Medipharm, a licensed pharma grade producer of medical cannabis products to produce EU GMP pharma grade high THC oils for international distribution. TheraLeaf is excited to enter the next phase of its global expansion with distribution of pharma grade THC tinctures in the 25:1 (THC: …

TheraLeaf announces application to UK’s MHRA for approval on medical cannabis tinctures

Barcelona, Spain – April 14th, 2020 TheraLeaf has officially applied to the United Kingdom’s Medicines and Healthcare Products Regulatory Agency (MHRA) for preliminary approval on its medical cannabis tinctures. TheraLeaf looks forward to providing all necessary documentation showing the safety, efficacy and specification of its medical cannabis products for UK distribution. Currently, the United Kingdom has over 20,000 patients in …